These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22334715)

  • 1. Reproductive and metabolic phenotype of a mouse model of PCOS.
    van Houten EL; Kramer P; McLuskey A; Karels B; Themmen AP; Visser JA
    Endocrinology; 2012 Jun; 153(6):2861-9. PubMed ID: 22334715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
    Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
    Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin protects against development of metabolic disturbances in a PCOS mouse model.
    Benrick A; Chanclón B; Micallef P; Wu Y; Hadi L; Shelton JM; Stener-Victorin E; Wernstedt Asterholm I
    Proc Natl Acad Sci U S A; 2017 Aug; 114(34):E7187-E7196. PubMed ID: 28790184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS).
    Brown RE; Wilkinson DA; Imran SA; Caraty A; Wilkinson M
    Brain Res; 2012 Jul; 1467():1-9. PubMed ID: 22668987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance.
    Morishita M; Endo T; Baba T; Kuno Y; Ikeda K; Kiya T; Honnma H; Saito T
    J Ovarian Res; 2018 Mar; 11(1):24. PubMed ID: 29580285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
    Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
    Caldwell AS; Eid S; Kay CR; Jimenez M; McMahon AC; Desai R; Allan CM; Smith JT; Handelsman DJ; Walters KA
    Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of DHT can relieve polycystic ovarian but not metabolic abnormalities in DHT-induced hyperandrogenism in mice.
    Sun LF; Yang YL; Xiao TX; Li MX; Zhang JV
    Reprod Fertil Dev; 2019 Sep; 31(10):1597-1606. PubMed ID: 31142430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
    Ryan GE; Malik S; Mellon PL
    Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
    Münzker J; Hofer D; Trummer C; Ulbing M; Harger A; Pieber T; Owen L; Keevil B; Brabant G; Lerchbaum E; Obermayer-Pietsch B
    J Clin Endocrinol Metab; 2015 Feb; 100(2):653-60. PubMed ID: 25387259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
    Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
    Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
    Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
    Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
    [No Abstract]   [Full Text] [Related]  

  • 15. MicroRNA-21 modulates brown adipose tissue adipogenesis and thermogenesis in a mouse model of polycystic ovary syndrome.
    Rezq S; Huffman AM; Basnet J; Alsemeh AE; do Carmo JM; Yanes Cardozo LL; Romero DG
    Biol Sex Differ; 2024 Jul; 15(1):53. PubMed ID: 38987854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose spironolactone-mediated androgen-adiponectin modulation alleviates endocrine-metabolic disturbances in letrozole-induced PCOS.
    Olaniyi KS; Oniyide AA; Adeyanju OA; Ojulari LS; Omoaghe AO; Olaiya OE
    Toxicol Appl Pharmacol; 2021 Jan; 411():115381. PubMed ID: 33359182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
    Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
    Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function?
    van Houten EL; Visser JA
    Reprod Biol; 2014 Mar; 14(1):32-43. PubMed ID: 24607253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the vascular responses in a murine model of polycystic ovary syndrome.
    Labruijere S; van Houten EL; de Vries R; Musterd-Bagghoe UM; Garrelds IM; Kramer P; Danser AH; Villalón CM; Visser JA; Van Den Brink AM
    J Endocrinol; 2013; 218(2):205-13. PubMed ID: 23734045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome.
    Lai H; Jia X; Yu Q; Zhang C; Qiao J; Guan Y; Kang J
    Biol Reprod; 2014 Nov; 91(5):127. PubMed ID: 25100714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.